Dilip Challa
Overview
Explore the profile of Dilip Challa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
30
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Challa D, de Rutte J, Konu C, Udani S, Liang J, Krohl P, et al.
bioRxiv
. 2024 Sep;
PMID: 39229089
Antibody discovery technologies, essential for research and therapeutic applications, have evolved significantly since the development of hybridoma technology. Various in vitro (display) and in vivo (animal immunization and B cell-sequencing)...
2.
Liao B, Tumanut C, Li L, Corper A, Challa D, Chang A, et al.
MAbs
. 2024 Jul;
16(1):2381261.
PMID: 39048914
Natural killer (NK) cells are key players in human innate immunity. Cell engager antibody formats that recruit and activate NK cells more effectively have emerged as a promising immunotherapy approach...
3.
Fagre A, Manhard J, Adams R, Eckley M, Zhan S, Lewis J, et al.
Front Immunol
. 2021 Jan;
11:614256.
PMID: 33391285
The emergence of COVID-19 has led to a pandemic that has caused millions of cases of disease, variable morbidity and hundreds of thousands of deaths. Currently, only remdesivir and dexamethasone...
4.
Fagre A, Manhard J, Adams R, Eckley M, Zhan S, Lewis J, et al.
bioRxiv
. 2020 Oct;
PMID: 33024962
The emergence of COVID-19 has led to a pandemic that has caused millions of cases of disease, variable morbidity and hundreds of thousands of deaths. Currently, only remdesivir and dexamethasone...